Chinese Journal of Pharmaceuticals
|
2025, 56(9): 1230-1236
• Pharmaceutical Management & Information •
A Freedom-to-operate Analysis of Deuterated Drugs
Full
Beiyan SHU1, Qinghua WANG2, Lei LIU3, Jia GENG4, Lifang SUN5, Jie ZHOU6, Wenjun GENG1, *
Affiliations
- 1.Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing 211122
- 2.Chemistry Examination Department of CNIPA’s Patent Office, Beijing 100088
- 3.Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221009
- 4.CSPC Pharmaceutical Group Co., Ltd., Shijiazhuang 050035
- 5.Luye Pharma Group Co., Ltd., Yantai 264003
- 6.North China Pharmaceutical Group Co., Ltd., Shijiazhuang 050015
Published: 2025-09-10
doi: 10.16522/j.cnki.cjph.2025.09.017
Outline
束蓓艳, 王青华, 刘雷, 耿佳, 孙丽芳, 周捷, 耿文军.
氘代药物在专利法意义上的自由实施分析.
中国医药工业杂志,
2025
, 56
(9)
: 1230
-1236
.
DOI: 10.16522/j.cnki.cjph.2025.09.017
Beiyan SHU, Qinghua WANG, Lei LIU, Jia GENG, Lifang SUN, Jie ZHOU, Wenjun GENG.
A Freedom-to-operate Analysis of Deuterated Drugs[J].
Chinese Journal of Pharmaceuticals,
2025
, 56
(9)
: 1230
-1236
.
DOI: 10.16522/j.cnki.cjph.2025.09.017
Year 2025 volume 56 Issue 9
30
7
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.09.017
- Receive Date:2025-01-20
- Online Date:2026-11-18
- Published:2025-09-10